Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11137 | 1005 | 20.4 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
451 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 16125 |
11137 | 1 | CEFUROXIME AXETIL//CEFPODOXIME PROXETIL//CEFTIBUTEN | 1005 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CEFUROXIME AXETIL | authKW | 422653 | 4% | 35% | 40 |
2 | CEFPODOXIME PROXETIL | authKW | 306239 | 2% | 40% | 25 |
3 | CEFTIBUTEN | authKW | 261163 | 2% | 36% | 24 |
4 | ORAL CEPHALOSPORIN | authKW | 189869 | 1% | 42% | 15 |
5 | CEFDINIR | authKW | 189049 | 2% | 27% | 23 |
6 | CEFETAMET PIVOXIL | authKW | 149566 | 1% | 62% | 8 |
7 | CEFACLOR | authKW | 128637 | 2% | 18% | 24 |
8 | CEFPROZIL | authKW | 89267 | 1% | 24% | 12 |
9 | CEFETAMET | authKW | 82698 | 1% | 39% | 7 |
10 | CEFOTIAM HEXETIL | authKW | 81016 | 0% | 67% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 9691 | 29% | 0% | 296 |
2 | Pharmacology & Pharmacy | 8950 | 55% | 0% | 550 |
3 | Microbiology | 5974 | 33% | 0% | 328 |
4 | Medicine, General & Internal | 302 | 10% | 0% | 96 |
5 | Medicine, Research & Experimental | 121 | 5% | 0% | 53 |
6 | Immunology | 100 | 7% | 0% | 67 |
7 | Chemistry, Analytical | 72 | 5% | 0% | 52 |
8 | Biochemical Research Methods | 32 | 3% | 0% | 29 |
9 | Pediatrics | 22 | 3% | 0% | 27 |
10 | Chemistry, Medicinal | 19 | 2% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACHARYA BM REDDY PHARM | 30382 | 0% | 100% | 1 |
2 | ADVANCED MAT CHAIR | 30382 | 0% | 100% | 1 |
3 | CHAIR CLIN HEMATOL INTENS THER Y | 30382 | 0% | 100% | 1 |
4 | CHEM NAT MICROBAL PROD | 30382 | 0% | 100% | 1 |
5 | CITY HOSP BERLIN ZEHLENDORF | 30382 | 0% | 100% | 1 |
6 | DIP SCI MATERNOINFANTILI | 30382 | 0% | 100% | 1 |
7 | FARMACEUT TECNOL FARMACEUT | 30382 | 0% | 100% | 1 |
8 | MED AFFAIRS CLIN MED | 30382 | 0% | 100% | 1 |
9 | PHARMACOKINET NANOTECHNOL GENE THER Y GRP PHAM | 30382 | 0% | 100% | 1 |
10 | POST MKT SURVEILLANCE 1 | 30382 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF DRUG DEVELOPMENT | 58580 | 1% | 21% | 9 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 18469 | 12% | 1% | 120 |
3 | INFECTIOUS DISEASES IN CLINICAL PRACTICE | 12687 | 2% | 2% | 19 |
4 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 11199 | 7% | 1% | 68 |
5 | DRUG INVESTIGATION | 10421 | 1% | 3% | 10 |
6 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 10031 | 4% | 1% | 42 |
7 | INFECTION | 9318 | 3% | 1% | 34 |
8 | CLINICAL THERAPEUTICS | 8811 | 4% | 1% | 38 |
9 | CHEMOTHERAPY | 6307 | 2% | 1% | 23 |
10 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 5297 | 3% | 1% | 29 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CEFUROXIME AXETIL | 422653 | 4% | 35% | 40 | Search CEFUROXIME+AXETIL | Search CEFUROXIME+AXETIL |
2 | CEFPODOXIME PROXETIL | 306239 | 2% | 40% | 25 | Search CEFPODOXIME+PROXETIL | Search CEFPODOXIME+PROXETIL |
3 | CEFTIBUTEN | 261163 | 2% | 36% | 24 | Search CEFTIBUTEN | Search CEFTIBUTEN |
4 | ORAL CEPHALOSPORIN | 189869 | 1% | 42% | 15 | Search ORAL+CEPHALOSPORIN | Search ORAL+CEPHALOSPORIN |
5 | CEFDINIR | 189049 | 2% | 27% | 23 | Search CEFDINIR | Search CEFDINIR |
6 | CEFETAMET PIVOXIL | 149566 | 1% | 62% | 8 | Search CEFETAMET+PIVOXIL | Search CEFETAMET+PIVOXIL |
7 | CEFACLOR | 128637 | 2% | 18% | 24 | Search CEFACLOR | Search CEFACLOR |
8 | CEFPROZIL | 89267 | 1% | 24% | 12 | Search CEFPROZIL | Search CEFPROZIL |
9 | CEFETAMET | 82698 | 1% | 39% | 7 | Search CEFETAMET | Search CEFETAMET |
10 | CEFOTIAM HEXETIL | 81016 | 0% | 67% | 4 | Search CEFOTIAM+HEXETIL | Search CEFOTIAM+HEXETIL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TODD, WM , (1994) CEFPODOXIME PROXETIL - A COMPREHENSIVE REVIEW.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 4. ISSUE 1. P. 37-62 | 50 | 88% | 9 |
2 | GUAY, DRP , (1997) CEFTIBUTEN: A NEW EXPANDED-SPECTRUM ORAL CEPHALOSPORIN.ANNALS OF PHARMACOTHERAPY. VOL. 31. ISSUE 9. P. 1022-1033 | 47 | 76% | 4 |
3 | BRYSON, HM , BROGDEN, RN , (1993) CEFETAMET PIVOXIL - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE.DRUGS. VOL. 45. ISSUE 4. P. 589-621 | 58 | 67% | 19 |
4 | KLEPSER, ME , MARANGOS, MN , PATEL, KB , NICOLAU, DP , QUINTILIANI, R , NIGHTINGALE, CH , (1995) CLINICAL PHARMACOKINETICS OF NEWER CEPHALOSPORINS.CLINICAL PHARMACOKINETICS. VOL. 28. ISSUE 5. P. 361-384 | 59 | 58% | 34 |
5 | GARCIARODRIGUEZ, JA , BELLIDO, JLM , SANCHEZ, JEG , (1995) ORAL CEPHALOSPORINS - CURRENT PERSPECTIVES.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 5. ISSUE 4. P. 231-243 | 50 | 68% | 9 |
6 | PERRY, CM , BROGDEN, RN , (1996) CEFUROXIME AXETIL - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY.DRUGS. VOL. 52. ISSUE 1. P. 125-158 | 58 | 49% | 34 |
7 | OWENS, RC , NIGHTINGALE, CH , NICOLAU, DP , (1997) CEFTIBUTEN: AN OVERVIEW.PHARMACOTHERAPY. VOL. 17. ISSUE 4. P. 707-720 | 37 | 77% | 9 |
8 | FRAMPTON, JE , BROGDEN, RN , LANGTRY, HD , BUCKLEY, MM , (1992) CEFPODOXIME PROXETIL - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL.DRUGS. VOL. 44. ISSUE 5. P. 889-917 | 42 | 78% | 30 |
9 | NEU, HC , (1995) ORAL BETA-LACTAM ANTIBIOTICS FROM 1960 TO 1994.INFECTIOUS DISEASES IN CLINICAL PRACTICE. VOL. 4. ISSUE . P. S39-S49 | 34 | 85% | 5 |
10 | FASSBENDER, M , LODE, H , SCHABERG, T , BORNER, K , KOEPPE, P , (1993) PHARMACOKINETICS OF NEW ORAL CEPHALOSPORINS, INCLUDING A NEW CARBACEPHEM.CLINICAL INFECTIOUS DISEASES. VOL. 16. ISSUE 5. P. 646-653 | 34 | 87% | 20 |
Classes with closest relation at Level 1 |